NextPharma
About
Company description
NextPharma is a leading European
Pharmaceutical Contract Development and Manufacturing Organisation (CDMO) with
sites located in Germany, France, Finland, Norway and the UK, and with healthcare
logistics services in the DACH region. With expertise in solids, semi solids
and non-sterile and ophthalmic liquids, the company provides services from
pharmaceutical development, clinical supplies, scale-up and process validation
through to commercial manufacturing for a large range of dosage forms including
tablets, capsules, softgels, granules, powders, pellets, gels, creams, sprays
and syrups. Each of our site is a centre of excellence including both
development and commercial capabilities with some specific niche expertise and
capabilities as for high potent, hormone, beta lactams, controlled drugs, lipid
based and modified release formulations, with Soft gel and liquid filled hard
shell technologies.
NextPharma can also supply a wide range of nutritional
products in dosage forms such as tablets, chewable tablets, liquids, softgel capsules and
ampoules. Our production sites, based in Europe, are to GMP standards and meet
European food regulation standards. We can also provide formulation development
and regulatory services to help our wide customer base meet the requirements of
the fast growing global food supplement market.
Quick facts
| Sales markets | Africa; Asia; Australia; Central/South America; Eastern Europe; Middle East; North America; Western Europe |
|---|---|
| Primary business activity | Contract Manufacturer |
| Affiliated categories: | Clinical trials |Contract manufacturing |Food Supplements / Nutraceuticals More |
